Medplus Health Services Subsidiary Receives Drug License Suspension Order
Medplus Health Services Limited announced that Optival Health Solutions Private Limited, a subsidiary, has received a suspension order for a Drug License affecting one of its stores. The order, received on March 20, 2026, suspends the Drug License for a period of seven days for the store located on Bhimavaram P P Road in Andhra Pradesh.The suspension is attributed to a violation of Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The potential financial impact of this suspension is estimated at a revenue loss of Rs 1.93 lacs.
Further details regarding the order are available on the company website at www.medplusindia.com, as well as the websites of the BSE Limited (www.bseindia.com) and the National Stock Exchange of India Ltd. (www.nseindia.com).
Manoj Kumar Srivastava, Company Secretary & Compliance Officer for Medplus Health Services Limited, confirmed the update.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Last edited by a moderator: